Company
IntoCell, Inc
IntoCell, Inc has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| ITC-6146RO | Phase 1 | Metastatic Castration-resistant Prostate Cancer |
Latest
No recent events.
Follow IntoCell, Inc on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.